Picture of Human Biobanking Technologies - Global Trends, Estimates and Forecasts, 2014-2020

Human Biobanking Technologies - Global Trends, Estimates and Forecasts, 2014-2020

June 2016


Global Market Watch:
Globally, Radio Frequency Identification & Tagging and Dry-State Storing together account for approximately 55% of the market share expected to support the Human Biobanking Technologies industry. Geographical analysis shows that the highest Compounded Annual Growth Rate (CAGR) of 10.14% is anticipated from Asia-Pacific region during the analysis period 2014-2020. North America and Europe together account for more than 50% of the global market share by end of 2020 respectively.

Report Focus:
The report “Human Biobanking Technologies - Global Trends, Estimates and Forecasts, 2014-2020” reviews the latest human biobanking market trends with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations. The report primarily focuses on:

·         Emerging market trends

·         Advancements in the technological space

·         Market demand of the segments (by-region)

·         Key growth areas and market size

·         Key competitor’s Edge

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.

The analysis primarily deals with human biobanking technologies market. Further, the subdivided categories include:

1.    Radio Frequency Identification (RFID) & Tagging

2.    Automated Liquid Handling

3.    Dry-State Storing

4.    Other

a.    Vitrification/Ultra-Fast Cooling Techniques

b.    Low Cryo Protectant Techniques

c.     Single-Nucleotide Polymorphism (SNP)

The period considered for the human biobanking technologies market analysis is 2014-2020. The region wise distribution of the market consists of North America (USA, Canada and Mexico), Europe (United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea and Rest of Asia-Pacific) and Rest of the World (Brazil, Middle East, South Africa, Rest of Latin America and Rest of Africa). The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years.

More than 1250 leading market players are identified and 107 key companies that project improved market activities in the near future are profiled. The report consists of 72 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.